About Curium Pharma
Curium Pharma is a company based in Paris (France) founded in 2017. It operates as a Direct-to-Consumer (D2C), Professional Services, and HealthTech. Curium Pharma has completed 4 acquisitions, including Cyclopharma, Monrol and NUCLEIS. Curium Pharma offers products and services including Radiopharmaceuticals, Generators, Cold Kits, and Hot Products. Curium Pharma operates in a competitive market with competitors including ImaginAb, AC Immune, ARTMS, APRINOIA and NorthStar Medical Radioisotopes, among others.
- Headquarter Paris, France
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Curium Bidco Sarl
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Investments & Acquisitions
Cyclopharma
& 3 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Curium Pharma
Curium Pharma offers a comprehensive portfolio of products and services, including Radiopharmaceuticals, Generators, Cold Kits, and Hot Products.
Radiopharmaceuticals are developed for diagnosis and treatment purposes.
Generators are provided for nuclear medicine diagnostic applications.
Cold kits are supplied for radiopharmaceutical preparation processes.
Hot products are offered for immediate medical use.
People of Curium Pharma
Unlock access to complete
Software Development Team
74 people
Leadership Team
39 people
Product Management Team
21 people
Sales and Marketing
20 people
Senior Team
15 people
Operations Team
12 people
Finance and Accounting
10 people
Human Resources and Administration
6 people
Unlock access to complete
Funding Insights of Curium Pharma
Investors in Curium Pharma
Curium Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include CapVest.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
CapVest is recognized as a leading private equity investor.
|
Locked | Locked | Locked |
Investor details for Curium Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Curium Pharma
Curium Pharma has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Cyclopharma, Monrol and NUCLEIS.
Investment portfolio details for Curium Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
PET radio-pharmaceutical drugs are manufactured under contract.
|
Locked | Locked | 2017 | Locked | |
|
Radiolabeling & radiopharmaceutical manufacturing services for nuclear medicine and molecular imaging
|
Locked | Locked | 2013 | Locked | |
|
Radiopharmaceuticals for molecular imaging are developed and manufactured.
|
Locked | Locked | 2000 | Locked |
Complete acquisition details for Curium Pharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Curium Pharma
Detailed financials for Curium Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Curium Pharma Comparisons
Peer comparison for Curium Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Curium Pharma
Curium Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ImaginAb, AC Immune, ARTMS, APRINOIA and NorthStar Medical Radioisotopes, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
ImaginAb is focused on developing advanced immuno-oncology imaging technologies.
|
|
| Locked | Locked | Locked |
Antibodies, small molecules, and vaccines are developed for neurodegenerative diseases.
|
|
| Locked | Locked | Locked |
Radioisotope technologies and services are developed and provided by ARTMS.
|
|
| Locked | Locked | Locked |
Diagnostics and therapeutics for neurodegenerative disorders are developed.
|
|
| Locked | Locked | Locked |
Provider of sourcing, purification, and separation technologies for the Nuclear Medicine market
|
|
| Locked | Locked | Locked |
Disease-modifying treatments for neurodegenerative diseases are developed.
|
Detailed competitors of Curium Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Curium Pharma
Complete news archive for Curium Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Curium Pharma
Curium Pharma was founded in 2017.
Curium Pharma is headquartered in Paris, France.
Renaud Dehareng is the current CEO of Curium Pharma.
Curium Pharma is established as a global leader in the field of nuclear medicine, specializing in radiopharmaceuticals. The company is focused on the development and supply of innovative products used for the diagnosis and treatment of various diseases. Operations are conducted across multiple sectors within healthcare, with solutions provided to over 35,000 patients daily. A diverse portfolio including generators, cold kits, and hot products is maintained, ensuring high-quality care through a network spanning over 70 countries. Commitment to safety and reliability is emphasized in every aspect of production and delivery.
Curium Pharma offers Radiopharmaceuticals, Generators, Cold Kits, and Hot Products.
Curium Pharma has made 4 acquisitions, including Cyclopharma, Monrol, and NUCLEIS.
Curium Pharma has 1 investor. Key investors include CapVest.